GC Biomaterials participates in AAP annual meeting

GC International

Wed. 11 November 2026

save

SEATTLE, US: GC Biomaterials recently participated in the 2026 annual meeting of the American Academy of Periodontology (AAP), presenting a scientific symposium as part of the AAP 2026 Corporate Forum, a series of industry-hosted presentations. GC’s programme featured two presentations examining the scientific rationale, material properties and clinical applications of carbonate apatite-based bone grafting materials in periodontal and implant dentistry.

In his lecture, “The evidence is mounting: Why you should have an alloplast in your regenerative armamentarium”, Dr Paul S. Rosen, a periodontist and clinical professor of periodontics at Rutgers School of Dental Medicine in the US, explored the available preclinical and clinical evidence supporting the use of alloplastic bone grafting materials. Drawing on clinical outcomes and human histological evidence, he discussed the scientific basis for using Cytrans Granules in regenerative procedures. He also highlighted Cytrans Elashield, a resorbable barrier membrane designed for guided bone regeneration.

Dr Robert Reti, an oral and maxillofacial surgeon in the US, gave a lecture titled “Carbonate apatite for ridge preservation: An engineered alternative to allografts”. His presentation examined the biological rationale behind carbonate apatite, its osteoconductive properties and its gradual replacement by newly formed bone. Dr Reti also provided an overview of the material composition, product characteristics and clinical applications of Cytrans Granules in alveolar ridge preservation.

The symposium was moderated by Dr Anton Sculean, professor of periodontics at the University of Bern in Switzerland, who facilitated discussions between the speakers and audience on the clinical applications of the materials presented. Commenting on the symposium, Prof. Sculean said: “It was an excellent symposium, featuring outstanding, scientifically rigorous and clinically relevant presentations, along with a highly engaged and enthusiastic audience. Cytrans Granules and Cytrans Elashield are highly innovative and excellent biomaterials, supported by scientific evidence and encouraging clinical experience. Together, they represent valuable innovations with significant potential to advance regenerative periodontal and implant therapy.”

In addition to the symposium, GC presented its biomaterial technologies at its exhibition booth, where representatives engaged with clinicians and researchers from the international periodontal community. Discussions focused on product characteristics, clinical applications and developments in regenerative dentistry. More information about GC Biomaterials can be found on the company’s website.